Semaglutide (GLP-1) in Karachi
The weekly injection known by brand names such as Ozempic and Wegovy, prescribed and monitored by a doctor as part of a structured weight management programme.
Is semaglutide right for me?
- For adults carrying significant extra weight, especially with a BMI of 30 or above, or 27 and above with a weight-related condition, who want medical help rather than another diet.
- A weekly injection with a very fine needle, started at a low dose and increased slowly by the doctor to keep side effects manageable.
- In large trials, average weight loss of around 15 percent of body weight over about 68 weeks, alongside better blood sugar and cardiovascular markers.
The medicine that changed weight management.
Semaglutide is a GLP-1 receptor agonist, a medicine that mimics a natural gut hormone released after eating. It slows stomach emptying, steadies blood sugar and acts on the appetite centres of the brain, so you feel satisfied with less food and the constant background noise of cravings quietens down.
It is best known by its brand names: Ozempic for type 2 diabetes, Wegovy for weight management, and Rybelsus as a tablet. In the landmark STEP trials, adults using weekly semaglutide with lifestyle support lost around 15 percent of their body weight on average, a result no diet programme reliably achieves.
Semaglutide is a serious prescription medicine, not a cosmetic quick fix. Used casually, it causes avoidable side effects and the weight returns when it stops. Used properly, inside a supervised programme that protects your muscle and builds habits, it can be the most effective tool a patient has ever had. That is how it is offered here.
What semaglutide helps with.
Average losses of around 15 percent of body weight in trials, continued over more than a year.
→ Appetite and cravingsActs on the brain's appetite centres, reducing hunger and the constant pull toward snacking.
→ Blood sugar controlOriginally a diabetes medicine, it improves insulin response and HbA1c.
→ Weight-related health risksIn trials, semaglutide reduced major cardiovascular events in people with obesity and heart disease.
→Good candidates
- Adults with a BMI of 30 or above, or 27 and above with a condition such as prediabetes, high blood pressure or sleep apnoea
- Patients whose weight has not responded to sustained lifestyle change
- People prepared to commit to follow-up, protein targets and strength training
Not suitable for
- A personal or family history of medullary thyroid cancer or MEN2 syndrome
- Pregnancy, planning pregnancy, or breastfeeding
- A history of pancreatitis
- Severe digestive disorders such as gastroparesis
- Known allergy to semaglutide or its components
- Type 1 diabetes, and diabetic eye disease requires specialist review first
How treatment works at the clinic.
Assessment first
After your assessment, treatment starts at a low weekly dose which is increased step by step over several weeks. This titration is where supervision matters most: it keeps nausea and digestive side effects manageable and finds the lowest dose that controls your appetite.
Protect the muscle
Weight loss medicines work on fat and muscle alike, so your programme includes protein targets and strength work to protect lean mass, with Emsculpt NEO available for patients who want additional muscle support. Follow-ups track your weight, side effects and progress, and the exit plan, how you keep the result, is discussed from the start rather than left to chance.
Your programme.
History, medicines, screening for contraindications and baseline measurements.
Low starting dose, increased gradually under the doctor's direction.
Regular reviews of weight, muscle, side effects and habits.
A plan for keeping the result, whether that is a maintenance dose or a structured taper.
Semaglutide or tirzepatide?
| What matters | Semaglutide | Tirzepatide |
|---|---|---|
| Receptors | GLP-1 | GIP and GLP-1 |
| Average trial weight loss | About 15% | Up to about 21% |
| Dosing | Once weekly | Once weekly |
| Track record | Longest of the new medicines | Newer, very strong data |
| Availability in Pakistan | Varies by brand | Registered (Mounjaro) |
Common early side effects are nausea, constipation and reflux, usually settling as the dose is titrated slowly. Gallbladder problems and dehydration are less common but monitored for. This is exactly why the medicine belongs inside a supervised programme.
"Semaglutide works, that is not in question. My concern is always how it is used. With proper screening, slow dosing and muscle protection, it is excellent medicine."
Consultant Dermatologist and Laser Specialist. Over 35 years of dermatology, trained in Zurich, practising in Clifton since 1999. Page medically reviewed October 2026.
Semaglutide and Ozempic, answered.
Straight answers from the clinic. If your question is not here, ask on WhatsApp.
Ask on WhatsAppOzempic is one brand of semaglutide, licensed for type 2 diabetes. Wegovy is the same molecule at weight management doses. The clinic prescribes semaglutide as part of a supervised weight programme where it is appropriate.
Availability of specific brands in Pakistan varies, and unofficial channels carry a high risk of counterfeits. The safe route is a clinic that assesses you, sources medication responsibly and supervises treatment. That is the service this programme provides.
In the STEP trials, adults lost around 15 percent of body weight on average over 68 weeks. Individual results vary with dose, habits and biology, which is why progress is reviewed rather than promised.
One injection a week under the skin of the abdomen or thigh with a very fine needle. We teach you the technique at the clinic, and most patients find it far easier than expected.
Appetite returns, and without a maintenance plan most people regain much of the weight. That is not a reason to avoid treatment, it is a reason to plan the exit properly, which we do from the first visit.
Any rapid weight loss includes some lean mass. Your programme includes protein targets and strength training, and muscle is monitored so the weight you lose is overwhelmingly fat.
Mostly digestive: nausea, constipation and reflux, especially while the dose increases. Slow titration keeps them manageable, and serious risks are screened for before you start.
The active molecule is synthetic, not animal derived. Patients who need certainty about excipients in a specific brand can discuss this at consultation.
Tirzepatide produced greater average weight loss in head to head trials, but tolerance, availability and your medical history all matter. Dr. Fehmida advises on both; read the tirzepatide page for the comparison.
No. The clinic prescribes GLP-1 medicines for weight management. Patients with diabetes are managed together with their physician or endocrinologist.
This page is for education and does not replace medical advice. Semaglutide is a prescription medicine, provided at the clinic only after an in-person medical assessment and only where clinically appropriate. Brand names such as Ozempic and Wegovy are the trademarks of their manufacturer and are referenced for identification only; the clinic is not affiliated with the manufacturer. Availability and regulatory status of specific products vary by market, and compounded preparations are not approved by regulators such as the FDA or DRAP. Individual results vary, and no outcome is guaranteed.
Book a weight management consultation.
An honest assessment of whether semaglutide fits your health profile, and a supervised plan if it does.
200/1 Clifton 1, Block 5, Clifton, Karachi. Monday to Friday 9:00 to 6:00, Saturday 9:00 to 5:00.
Call or WhatsApp 0301 827 9630